CD36 and lung carcinoma: CD36 overexpression has been reported to inhibit cell cycle arrest at the G0/G1 phase in lung cancer cells and promotes lung cancer progression; and CD36 inhibitors have a significant inhibitory effect on the growth of lung tumors (Sun et al., 2018).